Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1 [Fortune]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Fortune
As of Jan. 1, more than 250 branded drugs from pharmaceutical giants including Bristol Myers Squibb , Sanofi-Pasteur, Merck , and Pfizer , and more will see price hikes in the U.S., according to data analysis conducted by healthcare research firm 3 Axis Advisors. Related Video Pfizer alone is raising prices on over 60 drugs, the most on the list. (Pfizer has nearly 500 products in its portfolio.) In addition to a 3% increase on Paxlovid, its COVID treatment, Pfizer's cancer drugs Adcetris, Ibrance, and Xeljanz will now cost between 3% and 5% more, according to Reuters The median increase—which is only to the list price and does not include rebates or other discounts—is similar year-over-year at 4.5%. Still, more drugs are getting higher price tags in 2025 compared to last year. Pfizer told Fortune in a statement: “Pfizer has adjusted the average list prices of our medicines and vaccines for 2025 below the overall rate of inflation–approximately 2.4%–across many products in ou
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Spiral Tower in Hudson Yards Eyes $2.7 Billion Bond Refinancing [Yahoo! Finance]Yahoo! Finance
- Is Pfizer Inc. (NYSE:PFE) the Best January Dividend Stock to Buy? [Yahoo! Finance]Yahoo! Finance
- DIA's Global Pharmacovigilance Conference to Address Integrating AI and Real-World Evidence in Safety Workflows [Yahoo! Finance]Yahoo! Finance
- Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare ConferenceBusiness Wire
- Paxlovid Improved Long Covid Symptoms in Some Patients, Researchers Report [The New York Times]The New York Times
PFE
Earnings
- 10/29/24 - Beat
PFE
Sec Filings
- 1/3/25 - Form 4
- 1/3/25 - Form 4
- 1/3/25 - Form 4
- PFE's page on the SEC website